Johnson & Johnson (NYSE:JNJ) is a multinational pharmaceutical, consumer products and medical equipment company which has stood the test of time. The company, which was founded in 1886, is one of the 30 companies which make up the Dow Jones Industrial Average. The company is well diversified from the inside; they have 3 main business segments with over 250 subsidiaries operating under them. Johnson & Johnson is known for maximizing shareholder value with a long history of hiking dividends and also initiating share buyback programs. They are also one of the last two companies in the United States with a AAA credit rating. With them trading at a relatively fair P/E ratio of 20.4, it is safe to say that JNJ is a strong buy and hold.

The pharmaceutical industry is known for its volatility and competitive nature, it is particularly volatile to binary FDA decisions and political events. However, Johnson & Johnson has over 250 subsidiaries operating under 3 business divisions. Their 3 business divisions include a pharmaceutical division, a medical devices division and a consumer products division.

READ FULL ARTICLE HERE